| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; mouse; 1:100; loading ...; fig 4f
| Ji H, Xiong Y, Zhang E, Song W, Gao Z, Yao F, et al. Which has more stem-cell characteristics: Müller cells or Müller cells derived from in vivo culture in neurospheres?. Am J Transl Res. 2017;9:611-619 pubmed |
- immunocytochemistry; human; loading ...; fig 2bb
- western blot; human; loading ...; fig 2a
| Zhang C, Mukherjee S, Tucker Burden C, Ross J, Chau M, Kong J, et al. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Mol Oncol. 2017;11:280-294 pubmed publisher |
- immunocytochemistry; human; 1:100; fig 4
| Yuan Y, Yang Y, Tian Y, Park J, Dai A, Roberts R, et al. Efficient long-term cryopreservation of pluripotent stem cells at -80?°C. Sci Rep. 2016;6:34476 pubmed publisher |
- immunohistochemistry; human; 1:500; fig 6h
| Tardito S, Oudin A, Ahmed S, Fack F, Keunen O, Zheng L, et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat Cell Biol. 2015;17:1556-68 pubmed publisher |
- immunocytochemistry; human; 1:400; loading ...; fig 2a
| Mughal A, Grieg Z, Skjellegrind H, Fayzullin A, Lamkhannat M, Joel M, et al. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells. Mol Cancer. 2015;14:160 pubmed publisher |
- immunocytochemistry; human; fig S2B
- western blot; human; fig S2A
| Pastori C, Daniel M, Penas C, Volmar C, Johnstone A, Brothers S, et al. BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics. 2014;9:611-20 pubmed publisher |
- flow cytometry; human; loading ...; fig s8
| Yu P, Yan M, Lai H, Huang R, Chou Y, Lin W, et al. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. Int J Cancer. 2014;134:542-51 pubmed publisher |
| Zhang C, Ye W, Zhao M, Long L, Xia D, Fan Z. MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1. Int J Oral Sci. 2023;15:48 pubmed publisher |
| Zhang C, Ye W, Zhao M, Long L, Xia D, Fan Z. KDM6B Negatively Regulates the Neurogenesis Potential of Apical Papilla Stem Cells via HES1. Int J Mol Sci. 2023;24: pubmed publisher |
| Jung E, Osswald M, Ratliff M, Dogan H, Xie R, Weil S, et al. Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma. Nat Commun. 2021;12:1014 pubmed publisher |
| Nagaraja S, Quezada M, Gillespie S, Arzt M, Lennon J, Woo P, et al. Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State. Mol Cell. 2019;76:965-980.e12 pubmed publisher |
| Yuan Y, Park J, Tian Y, Choi J, Pasquariello R, Alexenko A, et al. A six-inhibitor culture medium for improving naïve-type pluripotency of porcine pluripotent stem cells. Cell Death Discov. 2019;5:104 pubmed publisher |
| Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, de la Grange P, et al. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS ONE. 2011;6:e18784 pubmed publisher |
| Delcroix G, Curtis K, Schiller P, Montero Menei C. EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation. 2010;80:213-27 pubmed publisher |
| Lim E, Vaillant F, Wu D, Forrest N, Pal B, Hart A, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15:907-13 pubmed publisher |
| Zou J, Maeder M, Mali P, Pruett Miller S, Thibodeau Beganny S, Chou B, et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 2009;5:97-110 pubmed publisher |
| Pietra G, Manzini C, Vitale M, Balsamo M, Ognio E, Boitano M, et al. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Int Immunol. 2009;21:793-801 pubmed publisher |
| Gago N, Pérez López V, Sanz Jaka J, Cormenzana P, Eizaguirre I, Bernad A, et al. Age-dependent depletion of human skin-derived progenitor cells. Stem Cells. 2009;27:1164-72 pubmed publisher |
| Griffero F, Daga A, Marubbi D, Capra M, Melotti A, Pattarozzi A, et al. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem. 2009;284:7138-48 pubmed publisher |
| Mali P, Ye Z, Hommond H, Yu X, Lin J, Chen G, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells. 2008;26:1998-2005 pubmed publisher |
| McGowan S, Edelhauser H, Pfister R, Whikehart D. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis. 2007;13:1984-2000 pubmed |
| Gordon M, Levicar N, Pai M, Bachellier P, Dimarakis I, Al Allaf F, et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822-30 pubmed |
| Grichnik J, Burch J, Schulteis R, Shan S, Liu J, Darrow T, et al. Melanoma, a tumor based on a mutant stem cell?. J Invest Dermatol. 2006;126:142-53 pubmed |
